Reformation of a Clinical Anti-Drug Antibody Assay to Enable the Immunogenicity Assessment of a Bispecific Antibody Biotherapeutic
Crossref DOI link: https://doi.org/10.1208/s12248-024-00996-6
Published Online: 2024-12-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Wenyu
Yang, Jie
Yan, Weili
Peng, Kun https://orcid.org/0000-0002-0480-073X
Text and Data Mining valid from 2024-12-12
Version of Record valid from 2024-12-12
Article History
Received: 5 September 2024
Accepted: 9 November 2024
First Online: 12 December 2024
Declarations
:
: All authors are employees of Genentech Inc., a member of the Roche group and Roche shareholders.